Study S003256

Effect of Injection Site on the Relative Bioavailability of a Single Dose of RAY1225 in Subjects With Low and High Body Mass Index

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06577428
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 48
Start: 2024-07-30
Primary completion: 2024-09-29
Lead sponsor: Guangdong Raynovent Biotech Co., Ltd
Conditions: Healthy
Interventions: DRUG:RAY1225
Results posted: FALSE

Registered primary outcomes

Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve of RAY1225 From Time Zero to Infinity (AUC[0-∞]) [DAY1~43]
PK: Maximum Concentration (Cmax) of RAY1225 [DAY1~43]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.